cdmo.directory
← Compare landing

AXOlabs vs Sinopep-Allsino Biopharmaceutical Co., Ltd.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axolabs/sinopep

CategoryAXOlabsSinopep-Allsino Biopharmaceutical Co., Ltd.
Listed sitebothcdmo
SummaryIntegrated CRO and CDMO specializing in nucleic acid therapeutics (ASOs, siRNA, sgRNA, aptamers) from lead identification through GMP manufacturing, with dual-site facilities in Petaluma, USA and Berlin, Germany.GMP peptide and oligonucleotide CDMO offering custom synthesis, NCE development, CMC manufacturing, and finished dosage form formulation services for therapeutic programs.
Services
  • Bioinformatics & Data Science
  • High-Throughput Screening
  • Target Identification & Validation
  • Discovery Research
  • GLP Toxicology
  • In Vivo PK / PD Studies
  • Bioanalysis
  • LC-MS Bioanalysis (Small Molecule)
  • In Vitro Pharmacology
  • Oligonucleotide Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Oligonucleotide
  • Peptide
  • Oligonucleotide
IndicationsData not yet provided.Data not yet provided.
Locations
  • Petaluma, Petaluma, California, USA
  • Berlin, Berlin, Berlin, Germany
  • Kulmbach, Kulmbach, Bavaria, Germany
Data not yet provided.
Certifications
  • GLP · Identifier: Statement of GLP Compliance (06 Dec 2024)
  • GMP · Identifier: Certificate of GMP Compliance (Regierung von Oberfranken, 14 Oct 2024)
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.